These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Expression profile of synaptic vesicle glycoprotein 2A, B, and C paralogues in temporal neocortex tissue from patients with temporal lobe epilepsy (TLE). Pazarlar BA; Aripaka SS; Petukhov V; Pinborg L; Khodosevich K; Mikkelsen JD Mol Brain; 2022 May; 15(1):45. PubMed ID: 35578248 [TBL] [Abstract][Full Text] [Related]
6. Differentiation of two human neuroblastoma cell lines alters SV2 expression patterns. Lekholm E; Ceder MM; Forsberg EC; Schiöth HB; Fredriksson R Cell Mol Biol Lett; 2021 Feb; 26(1):5. PubMed ID: 33588752 [TBL] [Abstract][Full Text] [Related]
7. SV2C is a synaptic vesicle protein with an unusually restricted localization: anatomy of a synaptic vesicle protein family. Janz R; Südhof TC Neuroscience; 1999; 94(4):1279-90. PubMed ID: 10625067 [TBL] [Abstract][Full Text] [Related]
8. SV2 is the protein receptor for botulinum neurotoxin A. Dong M; Yeh F; Tepp WH; Dean C; Johnson EA; Janz R; Chapman ER Science; 2006 Apr; 312(5773):592-6. PubMed ID: 16543415 [TBL] [Abstract][Full Text] [Related]
9. Expression pattern of synaptic vesicle protein 2 (SV2) isoforms in patients with temporal lobe epilepsy and hippocampal sclerosis. Crèvecoeur J; Kaminski RM; Rogister B; Foerch P; Vandenplas C; Neveux M; Mazzuferi M; Kroonen J; Poulet C; Martin D; Sadzot B; Rikir E; Klitgaard H; Moonen G; Deprez M Neuropathol Appl Neurobiol; 2014 Feb; 40(2):191-204. PubMed ID: 23617838 [TBL] [Abstract][Full Text] [Related]
10. SV2 mediates entry of tetanus neurotoxin into central neurons. Yeh FL; Dong M; Yao J; Tepp WH; Lin G; Johnson EA; Chapman ER PLoS Pathog; 2010 Nov; 6(11):e1001207. PubMed ID: 21124874 [TBL] [Abstract][Full Text] [Related]
12. Synaptic vesicle protein 2: A multi-faceted regulator of secretion. Ciruelas K; Marcotulli D; Bajjalieh SM Semin Cell Dev Biol; 2019 Nov; 95():130-141. PubMed ID: 30826548 [TBL] [Abstract][Full Text] [Related]
13. Reductions in Synaptic Vesicle Glycoprotein 2 Isoforms in the Cortex and Hippocampus in a Rat Model of Traumatic Brain Injury. Fronczak KM; Li Y; Henchir J; Dixon CE; Carlson SW Mol Neurobiol; 2021 Nov; 58(11):6006-6019. PubMed ID: 34435329 [TBL] [Abstract][Full Text] [Related]
14. SV2A and SV2C are not vesicular Ca2+ transporters but control glucose-evoked granule recruitment. Iezzi M; Theander S; Janz R; Loze C; Wollheim CB J Cell Sci; 2005 Dec; 118(Pt 23):5647-60. PubMed ID: 16306227 [TBL] [Abstract][Full Text] [Related]
15. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Lynch BA; Lambeng N; Nocka K; Kensel-Hammes P; Bajjalieh SM; Matagne A; Fuks B Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9861-6. PubMed ID: 15210974 [TBL] [Abstract][Full Text] [Related]
16. Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors. Peng L; Tepp WH; Johnson EA; Dong M PLoS Pathog; 2011 Mar; 7(3):e1002008. PubMed ID: 21483489 [TBL] [Abstract][Full Text] [Related]
17. Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons. Dong M; Liu H; Tepp WH; Johnson EA; Janz R; Chapman ER Mol Biol Cell; 2008 Dec; 19(12):5226-37. PubMed ID: 18815274 [TBL] [Abstract][Full Text] [Related]
18. Glycosylation is dispensable for sorting of synaptotagmin 1 but is critical for targeting of SV2 and synaptophysin to recycling synaptic vesicles. Kwon SE; Chapman ER J Biol Chem; 2012 Oct; 287(42):35658-35668. PubMed ID: 22908222 [TBL] [Abstract][Full Text] [Related]
19. Structural basis for botulinum neurotoxin E recognition of synaptic vesicle protein 2. Liu Z; Lee PG; Krez N; Lam KH; Liu H; Przykopanski A; Chen P; Yao G; Zhang S; Tremblay JM; Perry K; Shoemaker CB; Rummel A; Dong M; Jin R Nat Commun; 2023 Apr; 14(1):2338. PubMed ID: 37095076 [TBL] [Abstract][Full Text] [Related]